
|Articles|August 6, 2019
Technology Matters: Next-Generation RNA-Based Diagnostics Improve Disease Detection
Advertisement
Recent advancements in nucleic acid amplification tests (NAATs) have enabled clinicians to diagnose patients with improved accuracy for important pathogens. But are clinicians impeded by common misconceptions about available tools, or even key differences between DNA and RNA?
This supplement accurately explains the science of RNA-based testing modalities and reviews methods and results of assays for Mycoplasma genitalium, bacterial vaginosis, vulvovaginal candidiasis, Trichomonas vaginalis, and human papillomavirus.
Disclosures:
References:
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Phase 1 trial shows promise for triple-negative breast cancer vaccine
2
Broader genetic testing improves breast cancer risk detection
3
Top FDA approvals in women's health in 2025
4
COVID-19 vaccination during pregnancy reduces severe illness and preterm birth
5








